Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Br J Pharmacol
2000 May 01;1302:315-20. doi: 10.1038/sj.bjp.0703291.
Show Gene links
Show Anatomy links
Rapid desensitization of the TRH receptor and persistent desensitization of its constitutively active mutant.
Zaltsman I, Grimberg H, Lupu-Meiri M, Lifschitz L, Oron Y.
???displayArticle.abstract???
We studied rapid desensitization of the thyrotropin-releasing hormone receptor (TRH-R) or the m1-muscarinic receptor (m1-R) to a short challenge of threshold TRH concentration and persistent desensitization due to constitutive activity of a mutant TRH-R. Xenopus oocytes expressing TRH-Rs and/or m1-Rs were challenged for 15 s with threshold concentrations of TRH ([TRH]) and then immediately with supraoptimal [TRH] or acetylcholine ([ACh]). The threshold challenge caused desensitization of 50 - 57% of responses to subsequent supraoptimal stimulation with TRH or ACh. The homologous desensitization was reversible within 60 s after removal of the agonist. The protein kinase C (PKC) inhibitor, chelerythrine, inhibited the control responses by 30 - 40%, without affecting the desensitized responses. Chelerythrine or the phosphatase inhibitor, okadaic acid, had little effect on the kinetics of resensitization, indicating limited involvement of PKC. In oocytes coexpressing wild type TRH-Rs or m1-Rs with a constitutively active TRH-R mutant (C335Stop TRH-R), a persistent desensitization (33 - 57%) of the responses to TRH or ACh was observed. Additionally, there was a complete loss of the rapid desensitization induced by threshold [TRH]. Chlorodiazepoxide (CDE), a competitive binding antagonist of TRH-Rs and an inverse agonist of C335Stop TRH-Rs, abolished the persistent desensitization induced by C335Stop TRH-Rs and enabled the rapid desensitization, conferring the wild type phenotype on C335Stop TRH-Rs. Chelerythrine had qualitatively the same effect as CDE. In conclusion, unlike the rapid desensitization, the persistent desensitization caused by the constitutively active C335Stop TRH-Rs is largely mediated by PKC. It abrogates, however, the rapid desensitization, suggesting a common mechanistic step(s).
Arvanitakis,
Constitutively signaling G-protein-coupled receptors and human disease.
1998, Pubmed
Arvanitakis,
Constitutively signaling G-protein-coupled receptors and human disease.
1998,
Pubmed Barak,
Real-time visualization of the cellular redistribution of G protein-coupled receptor kinase 2 and beta-arrestin 2 during homologous desensitization of the substance P receptor.
1999,
Pubmed Grimberg,
Inverse agonist abolishes desensitization of a constitutively active mutant of thyrotropin-releasing hormone receptor: role of cellular calcium and protein kinase C.
1999,
Pubmed
,
Xenbase Heinflink,
A constitutively active mutant thyrotropin-releasing hormone receptor is chronically down-regulated in pituitary cells: evidence using chlordiazepoxide as a negative antagonist.
1995,
Pubmed Jinsi-Parimoo,
Constitutive activity of native thyrotropin-releasing hormone receptors revealed using a protein kinase C-responsive reporter gene.
1997,
Pubmed Kjelsberg,
Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation.
1992,
Pubmed Lipinsky,
Desensitization of the response to thyrotropin-releasing hormone in Xenopus oocytes is an amplified process that precedes calcium mobilization.
1995,
Pubmed
,
Xenbase Lupu-Meiri,
Extracellular calcium participates in responses to acetylcholine in Xenopus oocytes.
1990,
Pubmed
,
Xenbase Lupu-Meiri,
Calcium entry in Xenopus oocytes: effects of inositol trisphosphate, thapsigargin and DMSO.
1993,
Pubmed
,
Xenbase Matus-Leibovitch,
Truncation of the thyrotropin-releasing hormone receptor carboxyl tail causes constitutive activity and leads to impaired responsiveness in Xenopus oocytes and AtT20 cells.
1995,
Pubmed
,
Xenbase Oron,
Mechanism of membrane electrical response to thyrotropin-releasing hormone in Xenopus oocytes injected with GH3 pituitary cell messenger ribonucleic acid.
1987,
Pubmed
,
Xenbase Parma,
Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas.
1993,
Pubmed Pei,
A constitutively active mutant beta 2-adrenergic receptor is constitutively desensitized and phosphorylated.
1994,
Pubmed Saucier,
Endogenous serotonin-2A and -2C receptors in Balb/c-3T3 cells revealed in serotonin-free medium: desensitization and down-regulation by serotonin.
1998,
Pubmed Severi,
Progression from homologous to heterologous desensitization of contraction in gastric smooth muscle cells.
1999,
Pubmed Shapira,
Agonist-evoked calcium efflux from a functionally discrete compartment in Xenopus oocytes.
1996,
Pubmed
,
Xenbase Shapira,
Activation of two different receptors mobilizes calcium from distinct stores in Xenopus oocytes.
1990,
Pubmed
,
Xenbase Shenker,
A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty.
1993,
Pubmed Waugh,
Agonist-induced desensitization and phosphorylation of m1-muscarinic receptors.
1999,
Pubmed Yu,
Desensitization of thyrotropin-releasing hormone receptor-mediated responses involves multiple steps.
1997,
Pubmed
